SCHEMBL6823536

SCHEMBL6823536

COC(C)(C)CCCC(C)c1cnc(NC(=O)C(C)NC(=O)OC(C)(C)C)s1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 13/20 0.63
PSEN2 P49810 13/20 0.63
APH1B Q8WW43 13/20 0.63
NCSTN Q92542 13/20 0.63
APH1A Q96BI3 13/20 0.63
PSENEN Q9NZ42 13/20 0.63
GLS O94925 1/20 0.46
P2RY2 P41231 1/20 0.43
CCNE1 P24864 2/20 0.40
CDK2 P24941 2/20 0.40
CDK5 Q00535 2/20 0.40
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6824701 0.90 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6194071 0.89 PSEN1 (0.66) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6826674 0.89 PSEN1 (0.77) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5875643 0.86 PSEN1 (0.80) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5875548 0.86 PSEN1 (0.80) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8260305 0.86 PSEN1 (0.80) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6196140 0.83 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5875687 0.82 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8257247 0.82 PSEN1 (0.61) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6820532 0.82 CDK2 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040152747-A1 Thiazole compounds for treatment of neurodegenerative disorders PFIZER INC 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152747-A1 Thiazole compounds for treatment of neurodegenerative disorders APP, PARK7, IAPP PSEN1 5/4885PSEN2 7/4885APH1B 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.